Celleration, Inc., a leader in the medical technology industry, is headquartered in the United States and operates across various regions, focusing on advanced wound care solutions. Founded in 2004, the company has made significant strides in developing innovative products that enhance healing processes, particularly through its proprietary Mist Therapy technology. Celleration's core offerings include the MIST Therapy System, which utilises low-frequency ultrasound to promote tissue regeneration and accelerate wound healing. This unique approach sets Celleration apart in a competitive market, positioning it as a trusted partner for healthcare providers. With a commitment to improving patient outcomes, Celleration has achieved notable recognition within the industry, solidifying its reputation as a pioneer in non-invasive wound care solutions.
How does Celleration, Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Celleration, Inc's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Celleration, Inc, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Celleration, Inc may inherit climate commitments and emissions data from its parent organisation; however, no specific details regarding such cascaded data have been provided. This lack of information suggests that Celleration, Inc is still in the early stages of establishing its carbon footprint and climate strategy. In the context of the industry, it is essential for companies like Celleration, Inc to develop robust climate commitments and reduction initiatives to align with global sustainability goals. Without clear targets or emissions data, the company may face challenges in demonstrating its commitment to reducing its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Celleration, Inc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
